(Q52959035)

English

Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation.

scientific article published in March 2002

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Dual effects of arsenic trioxide (As2O3) on non-acute promyelocytic leukaemia myeloid cell lines: induction of apoptosis and inhibition of proliferation. (English)

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

1 reference

based on heuristic

inferred from title

arsenic trioxide

0 references

author name string

Rojewski MT

1

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Baldus C

2

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Knauf W

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Thiel E

4

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Schrezenmeier H

5

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

language of work or name

0 references

publication date

1 March 2002

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

British Journal of Haematology

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

116

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

3

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

555-563

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Arsenic trioxide induces apoptosis in neuroblastoma cell lines through the activation of caspase 3 in vitro

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Arsenic trioxide-induced apoptosis and differentiation are associated respectively with mitochondrial transmembrane potential collapse and retinoic acid signaling pathways in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Opposite effect of NF-kB and c-Jun N-terminal kinase on p53-independent GADD45 induction by arsenite

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Acute promyelocytic leukemia: cellular and molecular basis of differentiation and apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Treatment of acute promyelocytic leukemia with arsenic compounds: in vitro and in vivo studies

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Arsenic trioxide induces apoptosis of myeloid leukemia cells by activation of caspases

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

New retinoids and arsenic compounds for the treatment of refractory acute promyelocytic leukemia: clinical and basic studies for the next generation

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Involvement of CD95-independent caspase 8 activation in arsenic trioxide-induced apoptosis

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Apoptosis, bcl2 expression, and cell cycle analyses in nickel(II)-treated normal rat kidney cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Effect of arsenic trioxide on viability, proliferation, and apoptosis in human megakaryocytic leukemia cell lines

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Conjugation with the ubiquitin-related modifier SUMO-1 regulates the partitioning of PML within the nucleus

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Arsenic trioxide inhibits neuroblastoma growth in vivo and promotes apoptotic cell death in vitro.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Arsenic trioxide induces G2/M growth arrest and apoptosis after caspase-3 activation and bcl-2 phosphorylation in promonocytic U937 cells

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Effect of arsenic trioxide on cell cycle arrest in head and neck cancer cell line PCI-1.

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

PIC-1/SUMO-1-modified PML-retinoic acid receptor alpha mediates arsenic trioxide-induced apoptosis in acute promyelocytic leukemia

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Establishment and characterization of an arsenic-sensitive monoblastic leukaemia cell line (SigM5).

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Induction of apoptosis and inhibition of human gastric cancer MGC-803 cell growth by arsenic trioxide

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations

1 reference

https://api.crossref.org/works/10.1046%2FJ.0007-1048.2001.03298.X

21 January 2018

Identifiers

10.1046/J.0007-1048.2001.03298.X

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

release_ctprn3yjlrezdebocdqkr7oglm

1 reference

https://api.fatcat.wiki/v0/release/ctprn3yjlrezdebocdqkr7oglm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

9 May 2018

http://europepmc.org/abstract/MED/11849211

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q52959035&oldid=1842250736"